Sorafenib (Nexavar) Delays Rare Thyroid Cancer By 5 Months
Sorafenib (Nexavar) stops metastatic thyroid cancer tumor growth for nearly twice as long as a placebo, researchers from Abramson Cancer
Source: Health News
Posted in: AICHC News
Leave a Comment (0) ↓